Stocks
Iovance Biotherapeutics (IOVA) Debt/EBITDA US GAAP (year values) |
|||||||||
| 2021 | 2022 | 2023 | 2024 | 2025 | LTM ? | CAGR 5 years ? | |||
| Debt/EBITDA | 1.32 | 1.02 | 0.48 | 0.76 | 0.70 | 0.69 | |||
| Changes by years, y/y, % | -43% | -22% | -53% | +58% | -8% | -21.3% | |||
Iovance Biotherapeutics. Debt/EBITDA
Iovance Biotherapeutics. Debt/EBITDA, changes, %
Iovance Biotherapeutics (IOVA) Debt/EBITDA US GAAP (quarter values) |
||||||||
| 2024Q4 | 2025Q1 | 2025Q2 | 2025Q3 | 2025Q4 | LTM ? | |||
| Debt/EBITDA | 0.76 | 0.87 | 0.69 | 0.67 | 0.69 | 0.69 | ||
| Changes by years, y/y, % | +58% | +38% | -13% | -18% | -9% | |||
| Changes by quarters, q/q, % | -8% | +16% | -21% | -2% | +2% | |||
